Teads Stock Rises as Big Tech Drops, Traders Eye $1 Nasdaq Level

Teads Stock Rises as Big Tech Drops, Traders Eye $1 Nasdaq Level

June 5, 2026

NEW YORK, June 5, 2026, 15:03 EDT

  • Teads was last at $1.225, up 6.5%. QQQ, the ETF tracking big Nasdaq growth stocks, dropped around 4.5%.
  • Teads’ Nasdaq minimum-bid issue stays in the spotlight as the June 22 compliance deadline remains set.
  • CEO David Kostman picked up 46,500 shares between May 29 and June 2, according to a filing.

Teads Holding Co. shares rose Friday afternoon, gaining ground as most technology stocks fell. The small-cap ad tech company drew investor attention while working through its $1 share-price level.

The stock was last seen at $1.225, gaining 7.5 cents, and touched $1.245 at the session high. Market data put its value near $118 million. The jump came even as tech stocks broadly dropped after a solid U.S. jobs report stoked fear the Federal Reserve might keep its hawkish stance.

That’s what makes the move relevant now. Back in December, Teads said Nasdaq told the company its shares had traded under the $1 minimum bid for 30 sessions in a row. Nasdaq set a June 22 deadline for the company to fix the issue. To comply, Teads has to close at or above $1 for 10 straight days.

Insider buying at Teads is back on the tape. CEO Kostman picked up 18,000 shares on May 29, another 15,000 shares on June 1, and then 13,500 more on June 2. He paid between $1.0669 and $1.1936 a share, for about $53,000. With these trades, Kostman’s direct stake sits at 1.55 million shares, according to the latest Form 4.

Teads didn’t issue a Friday release on its press page. The most recent update was from earlier in the week, detailing an integration with Havas Media Network. Teads’ Audience Planning API was connected with Havas’ Converged.AI platform.

Jamie Seltzer, global chief data and technology officer at Havas Media Network, said the deal would add “precision and transparency” to audience activation. Remi Cackel, Teads’ chief product officer, said it was about “making audience activation seamless.” Teads

Teads investors are looking at whether agency workflow experience can lead to faster gains in connected TV, or CTV, where ads run on internet-connected televisions. In its first-quarter report last month, Teads said revenue slipped 7% to $266.0 million. Ex-TAC gross profit, which strips out what Teads pays partners for traffic, was up 5% to $107.9 million.

Teads had “accelerating momentum in CTV,” Kostman said at the time. But in that same report, adjusted EBITDA fell 93% to $0.8 million. Adjusted free cash flow moved to a $41.1 million outflow. SEC

The company kept its 2026 adjusted EBITDA target at around $100 million and is looking for second-quarter ex-TAC gross profit between $121 million and $131 million. The numbers put investors on alert for a stronger second quarter after a weak first, with attention fixed on more than just where the stock trades.

Peer names didn’t see the same action. The Trade Desk was down roughly 5.5%, Taboola shed 2.7% and Magnite eased 1.0%. Teads’ gains weren’t matched across ad tech stocks.

Nasdaq Composite dropped around 3.1% after chip stocks fell and May payroll numbers beat forecasts, Reuters said. “It’s another reason to believe that the Fed’s next move will be a hike,” said Peter Cardillo, chief market economist at Spartan Capital Securities, to Reuters. Reuters

Friday’s pop might not last. A reverse split would raise the share price by combining shares but wouldn’t solve cash flow, debt, or ad demand if those stay weak. Teads holders cleared a possible 1-for-5 to 1-for-25 split at the May 14 annual meeting, giving the board a say on timing and ratio.

Investors now turn to closing prices each day ahead of June 22. The main focus is whether those second-quarter numbers will show any profit lift from the Havas integration, connected TV, and cost cuts—or if those moves are just moving the price, not the bottom line.

Stock Market Today

  • Pro Medicus Secures $16M Ohio State Contract Renewal Amid Mixed Valuation Signals
    June 5, 2026, 2:47 PM EDT. Pro Medicus (ASX:PME) has renewed a $16 million, five-year contract with Ohio State University's Wexner Medical Center, boosting short-term stock momentum with a 4.03% gain in one day and a 25.24% rise over seven days. Despite strong three- and five-year returns, the stock is down 25.60% year to date and 39.77% over one year. The company trades at A$165.64, below a popular fair value estimate of A$196.78, suggesting possible undervaluation. However, its price-to-earnings (P/E) ratio sits at 73.7x, far exceeding industry averages around 28x, indicating pricey multiples and limited margin for error. Investors face contrasting signals between robust growth expectations and rich valuations amid contract renewal and recurring fee hikes.